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Abstract. We present a method to model pathologies in medical data,
trained on data labelled on the image level as healthy or containing a
visual defect. Our model not only allows us to create pixelwise semantic
segmentations, it is also able to create inpaintings for the segmentations
to render the pathological image healthy. Furthermore, we can draw new
unseen pathology samples from this model based on the distribution in
the data. We show quantitatively, that our method is able to segment
pathologies with a surprising accuracy and show qualitative results of
both the segmentations and inpaintings. A comparison with a super-
vised segmentation method indicates, that the accuracy of our proposed
weakly-supervised segmentation is nevertheless quite close.
1 Introduction
Supervised segmentation in medical image analysis is an almost solved problem,
where methodological improvements have a marginal effect on accuracy. Such
methods depend on a large annotated training corpus, where pixelwise labels
have to be provided by medical experts. In practice, such data are expensive
to gather. In contrast, weakly labelled data, such as images showing a certain
disease are easily obtainable, since they are created on a daily basis in medical
practice. We want to take advantage of these data for pathology segmentation,
by providing a means to finding the difference between healthy and pathological
data distributions. We present a weakly supervised framework capable of pixel-
wise segmentation as well as generating samples from the pathology distribution.
Our idea is inspired by CycleGAN [10], a recently proposed solution for
unpaired image to image translation, where the combination of domain-specific
generative adversarial networks (GANs) and so-called cycle consistency allow for
robust translation. We call our adaptation PathoGAN and count the following
contributions: We formulate a model capable of segmentation based on a single
label per training sample. We simultaneously train two generative models, able
to generate inpaintings at a localized region of interest to transform an image
from one domain to the other. We are able to sample healthy brains as well as
sample possible pathologies for a given brain. Furthermore, our method enforces
domain-specific information to be encoded outside of the image, which omits
adversarial “noise” common to CycleGAN [4] to some degree.
ar
X
iv
:1
80
5.
10
34
4v
1 
 [c
s.C
V]
  2
5 M
ay
 20
18
We show the performance of our implementation on 2d slices of the training
data of the Brain Tumor Segmentation Challenge 2017 [8,2] and compare our
segmentation performance to a supervised segmentation technique [1].
CycleGAN has been previously used to segment by transfering to another
target modality, where segmentation maps are available (e.g. [9]), or applied
to generate training from cheaply generated synthetic labelmaps [5]. Using a
Wasserstein GAN, another method directly estimates an additive visual attribu-
tion map [3]. To our knowledge, there has not been a method that jointly learns
to segment on one medical imaging modality using only image-level labels and
generate new data using GANs for both healthy and pathological cases.
2 Methods
2.1 Problem Statement
We assume two image domains A and B, where the former contains only images
of healthy subjects and the latter consists of images showing a specific pathology.
We seek to approximate the functions GA and GB that perform the mappings
(xA, δB) 7→ xˆB and (xB, δA) 7→ xˆA, where xA, xˆA ∈ A and xB, xˆB ∈ B. Vectors
δB and δA encode the missing target image information (e.g. the pathology):
xˆB = GA(xA, δB), xˆA = GB(xB, δA). (1)
In the remaining paper, we use X and Y as placeholders for A and B or B and A
to overcome redundancy due to symmetrical components. We encourage GA, GB
to produce results, such that the mappings are realistic (2), bijective (3), specific
(4) and that only the affected part in the image is modified (5):
GX(xX , δY ) ∼ Y, (2)
GY (GX(xX , δY ), δX) ≈ xX , (3)
GY (xX , 0) ≈ xX , (4)
GX ≈ arg min |xX −GX(xX , δY )|. (5)
2.2 Model Topology
To fulfill Eqs. (2–5), we adopt the main setup and objective from CycleGAN: we
employ two discriminators, DA and DB together with generators GA and GB
to perform the translation from domain A to B and vice versa, formulating two
generative adversarial networks (GANs) [6]. In both directions, the respective
discriminator is trained to distinguish a real image from the output of the gen-
erator, whereas the generator is incentivized to generate samples that fool the
discriminator.
Residual Generator In order to segment pathologies, we seek to only modify a
certain part of the image. In contrast to CycleGAN, we model the transformation
G from one domain to the other as a residual or inpainting p which is exchanged
with part l of the original image. We achieve this by letting generator GX directly
estimate n+ 1 featuremaps rX , where n is the number of image channels used.
We obtain labelmap lX and inpaintings pX , activating r
(0)
Y with a sigmoid and
each r
(i)
X with a tanh activation:
lX = S
(
r
(0)
X + 
)
, p
(i−1)
X = tanh
(
r
(i)
X
)
, (6)
where S (y) = 11+e−y and i > 0. With  ∼ N (0, I), we turn r(0)X +  into samples
from N (r(0)X , I) using the reparameterization trick [7]. This allows reliable cal-
culations of lX only for large absolute values of r
(0)
X , forcing lX to be binary and
intensity information to be encoded in the inpaintings. We set  to zero during
testing. From lX and pX we compute the translated result xˆY , supposedly in
domain Y now:
xˆY = lX  pX + (1− lX) xX .
In the following, we detail the computation of r for the two possible translation
directions. Both translation pathways are visualized in Fig. 1.
A → B To map from healthy to pathological data, we estimate rA (and thus
lA, pA) using a variational autoencoder (VAE) [7]. First, we employ encoders ΓA
and ∆B to encode anatomical information around and inside the pathological
region:
γA = Γ (xA), δB = ∆(l′B  x′B),
where xA is our healthy image, l′B and x
′
B are the labelmap and pathological
image of the previous transformation and δB, γA ∼ N (0, I). If l′B and x′B are not
available because xA is a real healthy image, we simply sample δy. Finally, a
decoder EA is applied to γA and δB:
rA = EA(γA, δB).
B → A To generate healthy samples from pathological images, we use a gener-
ator EB directly on the input as introduced in [10] and estimate r directly:
rB = EB(xB).
Here, we omit δA, since the location and appearance of missing healthy tissue
can be inferred from xB . We also omit using an encoding bottleneck due to
possible information loss and less accurate segmentation.
2.3 Objective
To train this model, a number of different loss terms are necessary. In the fol-
lowing, we explain the individual components using ·ˆ and ·˜ to denote results
from the translated and reconstructed images respectively (e.g. mapping xX
into Y results in xˆY , translating it back results in x˜X). We use λ. to weight the
contribution of different loss terms.
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Fig. 1. Proposed architecture: top to bottom: directions A → B → A and B → A → B;
xA, xB are samples from the two data distributions A,B and δB ∼ N (0, I). Red and
blue triangles depict decoder and encoder networks. A red square illustrates a simple
generators. ∆B and ΓA encode features inside and outside the pathological region.
∆B, ΓA and EA form a variational autoencoder. For GB , information about the missing
healthy structure is completely inferred from the surroundings.
CycleGAN As in CycleGAN [10], we formulate a least squares proxy GAN
loss, which we minimize with respect to GX and maximize with respect to DY :
LGAN(DY , GX , xX , xY ) = E[(DY (xY ))2] + E[(1−DY (GX(xX , δY )))2], (7)
Likewise, to make mappings reversible, we add the cycle consistency loss:
LCC(GX , GY , xX) = λCC||GY (GX(xX , δY ), δX)− xX ||1. (8)
LGAN and LCC encourage the properties defined in Eqs. (2) and (3).
Variational Autoencoder A variational autoencoder (VAE) is trained by
minimizing the KL-divergence of the distribution q(z|x) of encoding z to some
assumed distribution and the expected reconstruction error log p(x|z), where x
is the data. In contrast to a classical VAE, we use two distinct encoding vectors
γA and δB, encoding the healthy and the pathological part, and produce two
separate results, the labelmap lA and the inpainting pA. We directly calculate
the KL-divergence for our two encodings:
LKL(GA, GB, xA, xB) = KL[q(γA|xA)||N (0, I)] + KL[q(δB|xB, lˆB)||N (0, I)].
(9)
For the expected reconstruction error, we assume that l and p follow approxi-
mately a Bernoulli and a Gaussian distribution (N (µ, I)). We selectively penalize
the responsible encoding, by using separate loss functions for the residual region
and the rest. Unfortunately, we only ever have access to the ground truth of one
of these regions, since we do not use paired data. We solve this, by using the rel-
evant application in the network, where individual ground truths are available,
to calculate the approximation of the marginal likelihood lower bound:
LVAE(GX , GY , xX , xY ) =
− λVAE
N
N∑
m=1
(log p(l˜Y |γX , δY ) + log p(pˆX |γX) + log p(p˜Y |δY )),
(10)
where pˆX denotes the inpainting used to translate the original image xX to
domain Y and N is the total number of pixels. p˜X is the inpainting produced
when translating an already translated image xˆX that originated from Y back
to that domain. Similarly, lˆX and l˜X denote the respective labelmaps:
log p(pˆX |γX) = ||(1− lˆX)(pˆX − xX)||2
ω1
, log p(p˜X |δY ) = ||l˜Y (p˜X − xY )||2
ω2
(11)
where ω1 =
(
∑
(1−lˆX)+ε)
N and ω2 =
(
∑
(l˜Y )+ε)
N are considered constant during
optimization, with ε > 0. Finally, we use the labelmap produced by the other
generator responsible for the opposite transformation lˆY as ground truth for l˜X ,
where we consider lˆY constant in this term:
log p(l˜X |γX , δY ) = lˆY log l˜X + (1− lˆY ) log(1− l˜X). (12)
To restrict the solution space of our model, we use LVAE for both directions.
Identity Loss We apply an identity loss [10] on labelmap lX,xY which results
from feeding GX with the wrong input xY . In this case GX should not change
anything, since the input is already in the desired domain Y :
LIdt(GX , xY ) = λIdt||lX,xY ||1. (13)
Relevancy Loss By now, we have defined all necessary constraints for a suc-
cessful translation between image domains. The remaining constraints restrict
the location and amount of change, lX . Fulfilling Eq. (5), we want to entice label
map lX to be only set at locations of a large difference between inpainting pX
and image xX and penalize large label maps in general:
LR(GX , xX) = λR
[
|| − log(1− l2X)||1 −
||lX(xX − pX)||1
||lX ||1
]
. (14)
In order to not reward exaggerated pathology inpaintings, we consider (xX−pX)
constant in this expression.
Full PathoGAN Objective combining all loss terms for direction X to Y as
LX→Y , we can finally define:
LX→Y = LGAN + LCC + LVAE + LIdt + LR, (15)
LPathoGAN = LA→B + LB→A + λKLLKL(xA, xB). (16)
2.4 Training
We include all training patients of Brats2017 and normalize each brain scan
to follow N (0, 1/3), excluding zero voxels, and clip the resulting intensities to
[−1, 1]. We select all slices from 60 to 100. In order to create two distinct datasets
and relying on the manual segmentations, we label slices without pathology as
healthy, with more than 20 pixels segmented as pathological slices, and discard
the rest. For training, we select 1 500 unaffected and 6 000 pathological slices
from a total of 1 755 and 9 413 respectively1.
Since the BratS evaluation is volumetric and comparing performance is dif-
ficult, we also train a supervised segmentation technique on our data. We chose
MDGRU [1] for this task, a multi-dimensional recurrent neural network, due to
code availability and consistent state-of-the-art performance on different datasets.
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Fig. 2. Qualitative Results of one testing data example. Left columns, top to bottom:
the four available image channels x
(i)
B , the generated inpaintings pˆ
(i)
B and the translated
images xˆ
(i)
A . Right column, top to bottom: The manual segmentation lGS, the probability
maps lˆB from PathoGAN and lM from MDGRU for whole tumor.
1 Thus we would like to stress that the manual segmentations were only used to create
the two image domains, but not for the actual training.
3 Results
We train PathoGAN2 for 119 epochs using batches of 4 and λKL = 0.1, λR =
0.5, λIdt = 1, λCC = 5 and λVAE = 1. We trained MDGRU
3 as defined in [1],
using batches of 4 and 27 500 iterations. During training of both PathoGAN
and MDGRU, we use weak data augmentation [1]. Table 1 shows the results on
the pathological training and test data. On the left, Fig. 2 shows an exemplary
sample from the testset, with generated inpaintings and translation result. On
the right, we provide the generated labelmap together with the manual label for
“whole tumor” and the computed segmentation with MDGRU. Details on the
used architecture and training procedure as well as further qualitative samples
are described in the supplementary material.
Table 1. Segmentation Results. Columns: Dice, 95th percentile Hausdorff distance
(HD95), average Hausdorff distance (AVD) and volumetric Dice per-patient (Dice PP)
by stacking all evaluated slices. Rows: Scores are shown as mean±std(median) for
PathoGAN (proposed) and MDGRU, applied to training (Tr) and testing (Te) data.
Dice (in %) HD95 (in pixel) AVD (in pixel) Dice PP (in %)
PathoGAN (Tr) 72.4± 24.4(81.0) 40.6± 30.7(38.0) 10.3± 15.4(4.7) 77.4± 14.4(81.2)
PathoGAN (Te) 72.9± 23.8(81.4) 39.4± 29.9(37.6) 9.4± 13.7(4.6) 77.4± 14.4(81.7)
MDGRU (Tr) 87.8± 20.0(94.4) 3.7± 9.7(1.0) 1.0± 4.7(0.2) 90.8± 8.8(93.3)
MDGRU (Te) 86.3± 21.3(93.6) 3.9± 9.5(1.0) 1.1± 4.9(0.2) 90.6± 9.5(93.1)
4 Discussion
The results in Fig. 2 indicate that our relative weighting of the two inpainting
reconstruction losses results in better reconstruction inside the tumor region
than outside. The labelmaps of the supervised method compared to ours in Fig.
2 show great agreement, and both are relatively close to the gold standard. As
the 95th-percentile and average Hausdorff measures in Table 1 show, there are
some outliers in our proposed method, due to its weakly-supervised nature. The
Dice score is about 10% smaller for both the per-slice as well as the per-patient
case, given no labels are provided. It is important to remember that we segment
with the only criterion of being not part of the healthy distribution, which could
vary from the subjective measures used to manually segment data. The increase
in accuracy and decrease in standard deviation in the per-patient case for both
2 Our implementation is based on https://github.com/junyanz/
pytorch-CycleGAN-and-pix2pix.
3 We use the implementation of MDGRU at https://github.com/zubata88/
mdgru.
methods is most likely caused by the inferior segmentation performance in slices
showing little pathology. The per-patient Dice of the supervised method is in
the range of the top methods of BraTS 2017. Although not directly comparable,
this suggests that we can use our computed supervised scores as good reference
to compare our results to.
We did only scratch the surface on the possible applications of our pro-
posed formulation. Future work will include unaffected samples that are actually
healthy. Furthermore, the model architecture could be drastically simplified us-
ing one discriminator for both directions, allowing for larger generator networks
as well as using multiple discriminators at different scales to find inpaintings that
are not just locally but also globally consistent with the image. A restriction to
slices is unfortunate but necessary due to memory requirements. A generalisa-
tion of our approach to volumetric data would make it feasible for more real
clinical applications.
Conclusion We presented a new generative pathology segmentation model ca-
pable of handling a plethora of tasks: First and foremost, we presented a weakly
supervised segmentation method for pathologies in 2D medical images, where it
is only known if the image is affected by the pathology. Furthermore, we were
able to sample from both our healthy as well as our pathology model. We showed
qualitatively and quantitatively, that we are able to produce compelling results,
motivating further research towards actual clinical applications of PathoGAN.
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A Network structure
We use the same network architecture as in CycleGAN [10] for the discriminator.
The generator GA consists of two encoder networks and a decoder network.
Using a similar notation to the one used in the CycleGAN paper, our encoder
networks are defined as:
c7s1-64,d128,d256,d512,d1024,C1s1-15,Q2F,l(z*i)t,l(2*z).
cfs1-k denotes a convolution operation with f filters, stride 1 and k filters
combined with instance norm and exponential linear unit (ELU). A downsam-
pling operation of a stride 2, 3 × 3 convolution paired with an instancenorm
and following ELU is coded as dk. Cfs1-k is the same as cfs1-k without the
instance norm and activation. Q2F describes reshaping the 2d featuremaps to a
flat 1d vector. lk describes a fully connected layer with k output units, where
a trailing t denotes a following tanh activation. z stands for the encoding size
of 256 and i denotes the smallest image size before reshaping, in our case 15.
The output of the last layer is split in half to produce the mean and log variance
vectors of length 256 each.
Similarly, the decoder network is defined as:
l(i*i)e,l(i*i),F2Q,c3s1-1024,u512,u256,C7s1-256e,R256,R256,R256,
R256,R256,R256,R256,R256,R256,u128,u64,C7s1-r
We denote an additional ELU activation with a trailing e, F2Q describes the
reshaping operation from a vector to one square-shaped i × i featuremap, uk
means a transposed convolution followed by an instance norm and an ELU.
R stands for a Resnet block consisting of a residual computation with a 3x3
convolution layer with padding, an instance norm, an ELU and a 3x3 convolution
layer with padding, which is added to the input. r stands for the number of input
channels n+ 1. For both generators, one featuremap is activated with a Sigmoid
activation function and the rest with the tanh activation function.
The generator GB is slightly adjusted compared to [10]. We use exponential
linear units instead of rectified linear units for both generators and double each
layers number of featuremaps:
c7s1-64,d128,d256,R256,R256,R256,R256,R256,R256,R256,R256,R256,
u128,u64,C7s1-r
B Training Details: Data Augmentation
We augment our training data by randomly mirroring the samples, applying
a random rotation sampled from U [−0.1, 0.1] and a random scaling s = 1.1r
where r is sampled from U [−1, 1]. Furthermore we apply random deformations
as described in [1], with a grid spacing of 128 and sample the grid deformation
vectors from N (0, 5).
C Additional Visual Results
Additional visual results were randomly selected with the command ls testfolder
| shuf | tail -n 20 and are shown in Figs 3 to 22. The first row in the
figures shows the available sequences (FLAIR, T1CE, T1, T2) and the manual
segmentation, the second the respective generated inpaintings and probability
map and the last row shows on the left the four final translations for each se-
quence as well as the generated probability map using the supervised MDGRU[1]
reference method.
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Fig. 3. Random sample: HGG-Brats17_TCIA_335_1-73
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Fig. 4. Random sample: HGG-Brats17_CBICA_AQY_1-70
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Fig. 5. Random sample: HGG-Brats17_CBICA_AAG_1-71
xB lGS
pˆ
(i)
B lˆB
xˆ
(i)
A
FLAIR T1CE T1 T2
lM
prob. map
Fig. 6. Random sample: HGG-Brats17_CBICA_ABO_1-67
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Fig. 7. Random sample: LGG-Brats17_TCIA_630_1-60
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Fig. 8. Random sample: HGG-Brats17_TCIA_278_1-83
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Fig. 9. Random sample: LGG-Brats17_TCIA_177_1-64
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Fig. 10. Random sample: HGG-Brats17_TCIA_471_1-76
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Fig. 11. Random sample: HGG-Brats17_TCIA_296_1-62
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Fig. 12. Random sample: HGG-Brats17_TCIA_460_1-91
xB lGS
pˆ
(i)
B lˆB
xˆ
(i)
A
FLAIR T1CE T1 T2
lM
prob. map
Fig. 13. Random sample: HGG-Brats17_TCIA_198_1-68
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Fig. 14. Random sample: HGG-Brats17_CBICA_AOO_1-77
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Fig. 15. Random sample: HGG-Brats17_TCIA_218_1-65
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Fig. 16. Random sample: HGG-Brats17_TCIA_208_1-78
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Fig. 17. Random sample: HGG-Brats17_TCIA_606_1-83
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Fig. 18. Random sample: HGG-Brats17_2013_4_1-94
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Fig. 19. Random sample: LGG-Brats17_TCIA_645_1-79
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Fig. 20. Random sample: HGG-Brats17_CBICA_ANI_1-63
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Fig. 21. Random sample: HGG-Brats17_TCIA_332_1-79
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Fig. 22. Random sample: HGG-Brats17_CBICA_AQY_1-69
